RESUMEN
Heavy metals (HM) have gained significant attention in terms of regular monitoring and detection owing to their toxicity, non-biodegradability, and persistence. Current techniques for detecting HM are expensive, cumbersome, and require sophisticated instruments and skilled labour. Hence, developing cheap, rapid, energy-efficient, and accurate sensors is imperative and electrochemical techniques have emerged as promising tools. The current study involves the fabrication of an electrochemical sensor for the concurrent detection of lead (Pb2+) and cadmium (Cd2+) ions using modified carbon paste electrodes (mCPE). Activated carbon (AC) with a BET surface area of 1118â m2 g-1 was obtained by chemical activation and thermal treatment of the waste rubberwood sawdust. AC-Graphite, AC-Reduced Graphene Oxide (RGO), and AC-RGO-Chitosan were the types of mCPEs that were utilised. The electrochemical behaviours and effects of pH, concentration, and scan rate were studied using Cyclic voltammetry (CV). Studies on detection were conducted using CV and linear sweep voltammetry. Although all the 3 mCPEs detected Cd2+ and Pb2+ in the simulated wastewater, the CPE with RGO and AC could detect Cd2+ as low as 10.91â µg L-1 and Pb2+ as low as 14.01â µg L-1. The work explored the possibility of using AC as a potential sustainable substitute for graphite in CPE.
RESUMEN
Wilson's disease (WD) is an autosomal recessive disorder affecting the metabolism of copper that can present with a variety of clinical symptoms. Low levels of serum copper and ceruloplasmin, increased excretion of copper in the urine, and/or increasing quantities of copper in the liver are diagnostic indicators. The gold standard for diagnosis is genetic testing. The care approach includes the utilization of liver transplants as a therapeutic option in advanced patients and the use of copper-chelating medications. We describe a unique case of WD in a 14-year-old girl who presented with ascites, hemolytic anemia, and liver dysfunction. There was no indication of abdominal TB, and her viral, autoimmune, and hemolytic profiles were all normal. Low serum ceruloplasmin, elevated urine copper, and distinctive liver histology all supported the WD diagnosis. After starting penicillamine medication, the patient's symptoms improved, but her blood counts did not. This example emphasizes how crucial it is to rule out WD in patients with chronic liver disease, hemolytic anemia, and unexplained ascites, particularly in younger age groups.